000 | 01129 a2200325 4500 | ||
---|---|---|---|
005 | 20250514213820.0 | ||
264 | 0 | _c20050308 | |
008 | 200503s 0 0 fre d | ||
022 | _a0248-8663 | ||
024 | 7 |
_a10.1016/j.revmed.2004.06.014 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJabbour, E | |
245 | 0 | 0 |
_a[Acute tumor lysis syndrome: update on therapy]. _h[electronic resource] |
260 |
_bLa Revue de medecine interne _cJan 2005 |
||
300 |
_a27-32 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Review | ||
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 | _aFluid Therapy |
650 | 0 | 4 |
_aHematologic Neoplasms _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperuricemia _xetiology |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aTumor Lysis Syndrome _xpathology |
650 | 0 | 4 |
_aUrate Oxidase _xtherapeutic use |
700 | 1 | _aRibrag, V | |
773 | 0 |
_tLa Revue de medecine interne _gvol. 26 _gno. 1 _gp. 27-32 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.revmed.2004.06.014 _zAvailable from publisher's website |
999 |
_c15319142 _d15319142 |